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INTRODUCTION
Dairy producers and their advisors are confronted with a bewildering number of 
potential decisions or choices on a yearly, monthly, weekly, or even daily basis. These 
range from decisions relating to larger capital investments (e.g., a new milking center or 
conversion to automatic milking systems, a new transition cow barn, a new calf barn) to 
more modest capital investments (e.g., rumination tags, implementation of long day 
lighting, implementation of cooling in lactating and/or dry cows) to adoption of 
management practices (e.g., varying milking frequency, adjusting dry period length, 
adding an extra colostrum feeding or additional daily feeding to calves) to nutritional 
management decisions. Nutritional management decisions are also numerous and can 
relate to bigger picture decisions related to forage strategy or source, selection of dry 
and transition cow nutritional management strategies, or the decision to supplement 
specific nutrients or improved forms of nutrients or feed additives.
So, how can one sort through the decision-making process? My first
recommendation is to develop a systematic process for decision-making. In the 
remainder of this paper I will attempt to outline elements that I think should be 
considered as parts of this decision-making process.
ELEMENTS OF THE DECISIONMAKING PROCESS 
What is the "Reward-Risk”?
This phase is conventionally termed "risk-reward”, but I have inverted this 
intentionally as I think that the conventional manner in which we express this tends to 
subconsciously focus one on the risk rather than the potential reward. In order to 
consider the "reward-risk” we should consider the statistical concepts that Dr. Dave 
Galligan and colleagues at the University of Pennsylvania applied to the types of 
decisions that we make in dairy management (Galligan et al., 1991). They defined Type 
I error as the risk of an economically unprofitable outcome following the decision to 
implement a management practice or use of a product and Type II error as the risk of 
loss of potential profit by failure to adopt a particular technology or management 
practice and gave examples of how they would apply these concepts in the decision of 
whether or not to feed sodium bicarbonate and whether or not to administer rbST. From 
summaries of research studies they determined mean responses and variation around 
them, determined break-even responses based upon input costs and output values, 
calculated the frequencies of all possible responses, and then modeled the economics 
associated with both types of error, with additional sensitivity analysis conducted based
upon variance for both input costs and output values. For these particular examples, 
they determined that the Type II economic risk far exceeded the Type I economic risk.
I think that it is important to consider that the importance of Type I vs. Type II 
error in decision-making depends upon the particular type of decision to be made that in 
turn relates largely to the size of the investment and/or magnitude of commitment. As 
an example, in the case of large capital investments such as new milking centers or 
conversion of a herd from conventional milking systems to automatic milking systems, 
Type I error risk is the larger concern because in these cases Type I errors may 
meaningfully decrease profitability and/or put the dairy farm business at risk. In my 
opinion, Type I error risk should also receive primary consideration in the decision for a 
farm to plant non-GE crops as described in Joe Lawrence’s paper later in this 
conference, for significant pest or other crop system issues for which these technologies 
provide protection can have great impacts on overall profitability. For other 
management decisions (e.g., herd health and reproductive protocols, decisions to vary 
dry period length, nutritional strategies as will be discussed below), Type I errors are 
likely less of a problem and changes can be made relatively easily if it is determined 
that desired outcomes are not being achieved.
In general, I think that most decisions involving nutritional management are more 
at risk for Type II errors than Type I errors; however, my sense is that we generally 
focus more on the Type I risk than the Type II risk in these decisions. This is probably 
in large part because the input costs for adoption of a particular technology or nutritional 
strategy are easily determined and the specific response/value derived is often more 
challenging to determine, at least at the individual farm level given all of the other 
dynamic factors that can also influence outcomes of interest.
CONSIDERATIONS FOR ADOPTION OF MANAGEMENT PRACTICES OR 
NUTRITIONAL STRATEGIES AND TECHNOLOGIES
Of course, if we apply a purely Type II-centric decision-making approach, we 
may adopt many management practices, nutritional strategies, and technologies -  some 
of which will yield returns on the farm. There are a few things that I think should be 
considered when evaluating which adoption decisions to make.
Biology and Potential Mode of Action
In my opinion, understanding the biology and potential mode of action is critical. 
Of course, some things are quite well understood (e.g., rbST, milking frequency, 
controlled energy strategies for dry cows, application of DCAD in dry cows, responses 
to AA) and other emerging or integrative areas are less well-understood (e.g., gut 
integrity/leaky gut, oxidative metabolism, immune/inflammatory mechanisms). This 
does not de-emphasize the importance of these latter areas, rather it is important to 
recognize that we are still defining these areas and how to best modulate them in a 
positive manner through management and/or nutrition.
Develop a “Constellation of Evidence”
I think that decisions to adopt technologies have more certainty for success when 
responses are supported from various angles. Things that should be considered in the 
“constellation of evidence” are:
-- Biology and potential mode of action (see above)
-- Research and demonstration
-- Controlled, peer-reviewed University or Research Center work
-- Replicated (within dairy) commercial farm-based studies
-- Replicated (across dairies) commercial farm-based
studies/demonstration
-- Meta-analytic approaches
-- Practicality of implementation
-- Experience
Controlled, peer-reviewed research should form the basis for determining 
potential responses and defining mode of action; however, this work can be 
complemented nicely with commercial-farm based studies or demonstration. 
Furthermore, meta-analytic techniques are being applied increasingly to areas (e.g., 
effects of monensin on metabolism -  Duffield et al., 2008) in which there is a body of 
research that can be summarized using these approaches.
I would like to offer some “watch-out’s” relative to assessment of controlled 
studies, based upon nearly 25 years of experience and perspective gained over that 
timeframe doing these types of controlled studies in transition cow nutrition and 
management. First, many studies still are not well-replicated (we now strive for 25 to 30 
cows per treatment in transition cow studies in which we are trying to make inferences 
relative to performance). As such, outcomes can be particularly influenced by decisions 
that the investigators make relative to cow removal prior to analysis because of adverse 
health events. There are several recent examples of studies in which either large 
numbers of cows were removed from the dataset or cows were selectively removed for 
the same disorder from some treatments but not others, with potentially important 
consequences for the results and conclusions of the studies. A second “watch-out” 
relates to performance of controls. We strive to have studies in which the control group 
performance is representative of how cows perform on well-managed commercial 
farms. There are recent studies in which the performance responses to treatment were 
very large, but the control group was clearly compromised for whatever reason and 
performing well below what might be expected on a commercial dairy. A third “watch- 
out” relates to the discussion of what is “biologically or economically significant” versus 
“statistical significance”. Again, in studies that have relatively low replication, a 
difference that would be considered very meaningful at the farm level may not be 
statistically significant. A good example of this relates to work that several groups, 
including our own, did a number of years ago looking at continuous lactation (zero dry 
period). Cows with zero days dry generally made 1.5 to 3 kg/d less milk in the 
subsequent lactation but differences were not statistically significant. Finally, are the
results internally consistent within study (i.e., do changes in blood chemistry and/or 
body weight and body condition score line up with the responses in milk yield, milk 
composition, and dry matter intake observed?).
Projected Economic Returns
Of course, projected returns are a key consideration for adoption of technology. 
In addition to the approach that Galligan et al. (1991) illustrated, partial budget analysis 
to include changes in revenue or other benefits and changes in investment or inputs to 
determine marginal returns can be conducted. Within each of these, clear conveyance 
of the anticipated changes, consideration of whether the numbers and assumptions are 
hard or soft (level of certainty) is important. Furthermore, sensitivity of the final outcome 
to variation in response or changes in the input costs/output value should be evaluated.
Managing Expectations
Not every decision is going to be a home run, or even a hit. If there is 
heterogeneity in responses across studies on a topic, it should be represented in some 
manner. In my opinion, this helps to build credibility and take focus away from specific 
responses observed in an individual study and put it more on the pattern of responses 
seen across multiple studies.
What is the "Opportunity Cost” for Labor and Management?
Owners and managers on-farm as well as their advisors should keep in mind the 
opportunity cost for labor and management relative to adoption of management 
practices or technologies. This consideration will help to prioritize and keep focus on 
whether there are other management practices that would yield more potential return for 
the effort required to implement.
TWO EXAMPLES -  INCREASED MILKING FREQUENCY AND MONITORING AND
TREATMENT OF HYPERKETONEMIA
Assessment of 4X/2X Milking Strategies
A number of studies over the past 20 years have focused on increased milking 
frequency (IMF) of cows during the first 21 or so days postcalving. Following the 
original work in Israel in which cows milked 6X for the first 42 d postcalving maintained 
milk yields about 5 kg/d higher after return to 3X milking compared with cows milked 3X 
starting at calving, several studies evaluated 4X/2X milking schemes (fresh cows were 
generally milked first and again last in a 2X milking schedule) in University herds and on 
commercial dairy farms. These studies generally demonstrated carryover responses 
ranging from 2 to 4 kg/d of milk (Hale et al., 2003; Fernandez et al., 2004; Dahl et al., 
2004 Wall and McFadden, 2007; Soberon et al., 2010; Soberon et al., 20l1). The only 
study that demonstrated negative production responses to IMF was that of Van Baale et 
al. (2005) involving 6X/3X milking; however, they determined that on the large
commercial dairy in which they conducted the research, cows milked 6X were away 
from the fresh pen for milking more than 6 h per day, which likely had severely negative 
impacts on time budgets of those cows. Further, in our commercial farm-based work 
(Soberon et al., 2011), in general, the farms that had better management of stocking 
densities in the fresh pen and better transition management overall had better 
responses to IMF, although all farms in that dataset had a positive response to IMF.
Partial budget analysis suggested increased net revenue of about $80 per cow 
for adoption of 4X/2X milking, with most of the increased input cost associated with the 
increased feed requirements to support the additional milk yield. Changes in feed cost 
would be directly proportional to responses. Despite this, there has been very little 
adoption of this management practice on dairies milking 2X. Perhaps this is a 
perception of opportunity cost of labor and management, lack of confidence of seeing a 
response despite the available information, or simply lack of willingness to adopt a 
practice that will increase owner/manager labor on many of these dairies.
Monitoring and Treatment of Hyperketonemia
Following commercial-farm based research that established associations 
between cow- and herd-level prevalence of hyperketonemia (subclinical ketosis) and 
increased incidence of clinical disease, decreased milk yield, and impaired reproductive 
performance (Ospina et al., 2010a; 2010b, 2010c), McArt and coworkers conducted 
studies on four farms in New York and Wisconsin to determine the epidemiology of 
subclinical ketosis as well as the outcomes of intensive testing and treatment strategies 
using handheld BHBA meters and propylene glycol drench as a treatment regimen 
(McArt et al., 2011; 2012a; 2012b). They demonstrated increased milk yield, decreased 
DA, decreased herd removal, and increased first service conception rate for cows 
detected and treated with propylene glycol. Further economic analysis of varying 
intensities of testing with associated propylene glycol treatment yielded net returns 
ranging from $7 to $11 per cow for herds with 40% incidence (~ 2x  prevalence) and 
greater returns for herd with higher prevalence and incidence. Although the economic 
returns of intensive diagnostics and associated treatment are favorable, there is likely 
an opportunity cost of management and labor that should be considered. At a 
minimum, schemes such as the one in Figure 1 that Ospina et al. (2013) proposed to 
monitor prevalence with management decision-making based upon prevalence can be 
very effective ways to monitor and manage hyperketonemia in a targeted manner.
SUMMARY AND CONCLUSIONS
Decision-making at the herd level can be complex for both dairy producers and 
their advisors. Having a process that is systematic and that considers multiple aspects 
and implications of decisions can lead to better decision-making overall. Producers and 
their advisors should weigh the "reward-risk” of decisions, and not let concern about 
making Type I errors result in greater losses through Type II errors related to failure to 
adopt technologies or management practices. Developing a "constellation of evidence” 
consisting of biological mode of action, research and demonstration to support,
likelihood of effective implementation, and experience can help to determine which 
adoption decisions to make, keeping in mind management systems, practicality, and 
opportunity cost for labor and management.
Figure 1. Testing scheme for prevalence of hyperketonemia in fresh cows with 
associated recommendations for monitoring and treatment. From Ospina et 
al., 2013.
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